This 14 September 2021 session covered: medicines optimisation for cardiovascular diseases such as atrial fibrillation, heart failure (HF); newly emerging therapies for HF; and ischaemic heart diseases.

Speakers:

- Helen Williams, Consultant Pharmacist, South East London
- Rachel Howatson, Senior Cardiovascular Pharmacist, South London

свернуть